IVA Inventiva SA Forecast, Technical & Fundamental Analysis

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

IVA is expected to report earnings to rise 31.83% to -63 cents per share on September 25

Q2'24

Est.

$-0.63

Q1'24

Beat

by $0.04

Q4'23

Beat

by $0.04

Q3'23

Missed

by $0.48

Q2'23

Missed

by $0.51

The last earnings report on May 21 showed earnings per share of -47 cents, beating the estimate of -51 cents. With 5.35K shares outstanding, the current market capitalization sits at 126.12M.

A.I. Advisor

published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

50 rue de Dijon

Phone

+33 380447500

Employees

123

Web

https://www.inventivapharma.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
SATOX	15.13	-0.01	-0.07%
AllianceBern Tax–Aware Overlay A 1
PNOTX	21.85	-0.09	-0.41%
Putnam Sustainable Future R6
FTQGX	37.72	-0.21	-0.55%
Fidelity Focused Stock
RYVFX	10.32	-0.08	-0.77%
Royce Small-Cap Value Service
LMCPX	34.31	-0.29	-0.84%
Lord Abbett Mid Cap Stock P

IVA and Stocks

Correlation & Price change

A.I.dvisor tells us that IVA and OCGN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVA and OCGN's prices will move in lockstep.

Ticker / NAME	Correlation To IVA	1D Price Change %
IVA	100%	-2.18%
OCGN - IVA	24% Poorly correlated	+1.72%
THAR - IVA	24% Poorly correlated	-2.46%
IMMP - IVA	23% Poorly correlated	+1.38%
MRNA - IVA	23% Poorly correlated	+1.31%
KRBP - IVA	23% Poorly correlated	+2.56%
More